This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Clinical Trials Europe

Sarah Bilali
Director, Global Regulatory Affairs Devices at UCB


Sarah Bilali has been working in the clinical research space for the past 20 years. She is currently Director of Global Regulatory Affairs for Medical Devices in the Global Regulatory Affairs UCB Biosciences Inc, located in Raleigh, NC. Sarah began her research career as a study coordinator at a clinical trial academic site and worked in data management, statistics, and clinical operations. Sarah then expanded her career development into the device clinical trial industry where she worked as an auditor in quality assurance. In 2010, Sarah joined the UCB Pharma in Clinical Quality Assurance In 2015, Sarah has been spearheading efforts for UCB on the integration of medical devices into the clinical trial pharma environment.

In 2018 Sarah joined the newly formed Medical Device Quality Assurance organization to lead quality support for medical device clinical trial activities with a specific focus on digital devices. In 2020, Sarah took on a new role in Global Regulatory Affairs as Global Regulatory Lead-Devices to develop regulatory strategy for UCB in the sensor, mobile app and algorithm based software as a medical device products. She and her team currently support activities of all product development phases.

Sarah holds a Bachelor of Science in Psychology from Muskingum University and Master of Arts in Psychology Experimental Research from Cleveland State University.

Agenda Sessions

  • VIRTUAL: Regulatory Considerations in Digital Clinical Innovation: A Risk Based Approach

  • PANEL: Trying to Define what AI Actually Means in Clinical Trials